CEFPROZIL and RASH

Overview

RASH is the #5 most commonly reported adverse reaction for CEFPROZIL, manufactured by Ascend Laboratories, LLC. There are 57 FDA adverse event reports linking CEFPROZIL to RASH. This represents approximately 2.4% of all 2,368 adverse event reports for this drug.

Patients taking CEFPROZIL who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

RASH is a less commonly reported adverse event for CEFPROZIL, but still significant enough to appear in the safety profile.

Other Side Effects of CEFPROZIL

In addition to rash, the following adverse reactions have been reported for CEFPROZIL:

• CHRONIC KIDNEY DISEASE — 89 reports
• DRUG HYPERSENSITIVITY — 73 reports
• COUGH — 61 reports
• ACUTE KIDNEY INJURY — 59 reports
• DYSPNOEA — 53 reports
• PNEUMONIA — 53 reports
• PYREXIA — 53 reports
• RENAL FAILURE — 52 reports
• FATIGUE — 50 reports
• DIARRHOEA — 49 reports

Other Drugs Associated with RASH

The following drugs have also been linked to rash in FDA adverse event reports:

Does CEFPROZIL cause RASH?

RASH has been reported as an adverse event in 57 FDA reports for CEFPROZIL. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is RASH with CEFPROZIL?

RASH accounts for approximately 2.4% of all adverse event reports for CEFPROZIL, making it a notable side effect.

What should I do if I experience RASH while taking CEFPROZIL?

If you experience rash while taking CEFPROZIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages